红细胞5ALA合成障碍的小鼠模型及其对吡哆醇的条件性合成致死依赖
研究利用CRISPR-CAS9基因编辑和条件性基因打靶构建了XLSA、XLPP及SLC25A38-CSA小鼠模型,并观察膳食吡哆醇限制或补充对贫血和卟啉症的影响。结果显示XLPP/EPP原卟啉症对吡哆醇相对不敏感,XLSA模型敏感,SLC25A38-CSA模型对吡哆醇缺乏极度敏感,且该表型不见于Hbbth3/+中间型β地中海贫血小鼠模型。
要点
- 成功构建了模拟XLSA、XLPP和SLC25A38-CSA主要特征的小鼠模型。
- XLPP/EPP原卟啉症对吡哆醇补充相对不敏感,而XLSA模型敏感。
- SLC25A38-CSA模型对吡哆醇缺乏极度敏感,该表型不见于Hbbth3/+中间型β地中海贫血小鼠模型。
核心结论
- 研究构建了可用于研究XLSA、XLPP和SLC25A38-CSA病理生理及治疗的动物模型,并发现血红素合成相关先天性铁粒幼细胞性贫血与吡哆醇缺乏之间存在条件性合成致死。
- 这些发现可能为这些疾病的治疗提供新的治疗范式。
研究设计与样本
- 利用CRISPR-CAS9基因编辑技术构建模拟XLSA和XLPP主要特征的敲入小鼠模型。
- 利用胚胎干细胞中的常规条件性基因打靶构建SLC25A38-CSA的忠实模型。
- 研究观察各疾病模型的表型和自然史,并检测膳食吡哆醇(维生素B6)限制或补充对贫血和卟啉症的影响。
主要发现
- XLSA突变对吡哆醇补充有明确反应,XLPP/EPP原卟啉症相对不敏感,XLSA模型对吡哆醇缺乏严重敏感。
- SLC25A38-CSA模型对吡哆醇缺乏极度敏感,该表型不与Hbbth3/+中间型β地中海贫血小鼠模型共享。
- 研究揭示了血红素合成相关先天性铁粒幼细胞性贫血与吡哆醇缺乏之间未被怀疑的条件性合成致死。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
X-linked sideroblastic anemia (XLSA) and X-linked protoporphyria (XLPP) are uncommon diseases caused by loss-of-function and gain-of-function mutations, respectively, in the erythroid form of 5-aminolevulinic acid synthetase (ALAS), ALAS2, which encodes the first enzyme in heme biosynthesis. A related congenital sideroblastic anemia (CSA) is due to mutations in SLC25A38 (solute carrier family 25 member A38), which supplies mitochondrial glycine for ALAS2 (SLC25A38-CSA). The lack of viable animal models has limited the studies on pathophysiology and development of therapies for these conditions. Here, using CRISPR-CAS9 gene editing technology, we have generated knockin mouse models that recapitulate the main features of XLSA and XLPP; and using conventional conditional gene targeting in embryonic stem cells, we also developed a faithful model of the SLC25A38-CSA. In addition to examining the phenotypes and natural history of each disease, we determine the effect of restriction or supplementation of dietary pyridoxine (vitamin B6), the essential cofactor of ALAS2, on the anemia and porphyria. In addition to the well-documented response of XLSA mutations to pyridoxine supplementation, we also demonstrate the relative insensitivity of the XLPP/EPP protoporphyrias, severe sensitivity of the XLSA models, and an extreme hypersensitivity of the SLC25A38-CSA model to pyridoxine deficiency, a phenotype that is not shared with another mouse hereditary anemia model, Hbbth3/+ β-thalassemia intermedia. Thus, in addition to generating animal models useful for examining the pathophysiology and treatment of these diseases, we have uncovered an unsuspected conditional synthetic lethality between the heme synthesis-related CSAs and pyridoxine deficiency. These findings have the potential to inform novel therapeutic paradigms for the treatment of these diseases.
引用
- Ducamp S, Sendamarai AK, Campagna DR, et al. Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine. Blood. 2024. PMID: 38900972. doi:10.1182/blood.2023023078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。